Your daily news update on Asia and the Pacific

Provided by AGP

The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on May 19, 2026

Lawn Mower Market worth $36.33 billion by 2032 | MarketsandMarkets™
D’CENT Launches ‘Flare Campaign’ to Unlock Idle XRP for the Global XRP Army
SpecterAI Quantum Security và CCLab Ký Kết Hợp Tác Chiến Lược, Cấp Chứng Nhận An Ninh Mạng Và Hậu Lượng Tử
Shufti Recognised as Dual Leader in Liminal's 2026 Age Verification and Age Estimation Indexes, with Exceptional Ratings
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
Curia schließt die Modernisierung der API-Aseptik-Anlagen in Valladolid, Spanien, ab
Curia completa la modernización de sus salas asépticas de API en Valladolid, España
Curia achève la modernisation de ses unités aseptiques de fabrication d’API à Valladolid, en Espagne
קוריה משלימה שדרוג של חדרי API אספטיים בוואלאדוליד, ספרד
Curia Menyelesaikan Peningkatan pada Ruang Aseptik API di Valladolid, Spanyol
キュリア、スペインのバリャドリッドにあるAPI無菌製造施設のアップグレードを完了
Curia Global, 스페인 바야돌리드 API 무균 생산 시설 업그레이드 완료
Curia Menyelesaikan Penaiktarafan Suite Aseptik API di Valladolid, Sepanyol
Curia Finaliza Upgrade de Suítes Assépticas API em Valladolid, Espanha
Curia ดำเนินการปรับปรุงห้องปฏิบัติการปลอดเชื้อสำหรับผลิต API ในเมือง Valladolid ประเทศสเปน…
Curia完成了西班牙巴利亚多利德API无菌生产线升级
Curia 位於西班牙華拉度列的活性藥物成分無菌設施順利完成升級
Luda Technology Group Limited Announces Appointment of Authorized Agents Across Brazil, Colombia, Bolivia, Ecuador and Malaysia to Accelerate Global Expansion
MAAS Subsidiary, Huazhi Future, Explores Green AI Computing Collaboration with Xinjiang Delegation and CGN
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients

Share us

on your social networks:

Sign up for:

The Asia Pacific Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.